Vanderbilt University Medical Center has received the first doses of a new shot that will prevent COVID-19.
Dr. Robert Carnahan with the Vanderbilt University Medical Center says the shot, called Evusheld, is a new combination of antibodies.
Evusheld is currently the only antibody combination given by intramuscular injection to protect uninfected people from COVID-19.
Because of the limited supply, Evusheld will be given only to the highest risk patients, including transplant recipients and those being treated for cancer.
Caroline Davis is the first recipient at Vanderbilt of the newly approved shot to prevent COVID-19.
“It was a very, very exciting day for me,” says Davis.
She is being treated for cancer which has hot her immune system hard.
“It’s been pretty much pretty much home bound for the past for the past year. So, this gives me a little bit of confidence that I can go out,” says Davis.
VUMC was among the first to receive doses from Tennessee allotment of about 1,000 doses, officials said.
Just like the other antibody treatments already being used, after people get sick there is not enough to go around.